---
figid: PMC8294190__fphar-12-695957-g001
figtitle: 'Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive
  Pulmonary Disease?'
organisms:
- NA
pmcid: PMC8294190
filename: fphar-12-695957-g001.jpg
figlink: /pmc/articles/PMC8294190/figure/F1/
number: F1
caption: Schematic represent IL-17 family subgroup and their corresponding receptors
  from IL-17 receptor family. IL-17A, IL-17A/F and IL-17F share the IL-17RA/RC heterodimeric
  receptor. The intracellular domains of all IL-17R encode conserved SEFIR domains
  which interact with a corresponding SEFIR motif on the adaptor Act1, then they combine
  with TRAF6 to activate the pathway of NF-κB and MAPK. However, TRAF3 could inhibit
  SEFIR- Act1- TRAF6 pathway by competitive binding the IL-17RA directly. Only IL-17RA
  own the CBAD and TILL, which can promote the target gene expressions via C/EBP β
  pathway.
papertitle: 'Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive
  Pulmonary Disease?.'
reftext: Meiling Liu, et al. Front Pharmacol. 2021;12:695957.
year: '2021'
doi: 10.3389/fphar.2021.695957
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: IL-17A | COPD | inflammation | cytokine | chemokine | treatment
automl_pathway: 0.9642538
figid_alias: PMC8294190__F1
figtype: Figure
organisms_ner:
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC8294190__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8294190__fphar-12-695957-g001.html
  '@type': Dataset
  description: Schematic represent IL-17 family subgroup and their corresponding receptors
    from IL-17 receptor family. IL-17A, IL-17A/F and IL-17F share the IL-17RA/RC heterodimeric
    receptor. The intracellular domains of all IL-17R encode conserved SEFIR domains
    which interact with a corresponding SEFIR motif on the adaptor Act1, then they
    combine with TRAF6 to activate the pathway of NF-κB and MAPK. However, TRAF3 could
    inhibit SEFIR- Act1- TRAF6 pathway by competitive binding the IL-17RA directly.
    Only IL-17RA own the CBAD and TILL, which can promote the target gene expressions
    via C/EBP β pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - il17ra1a
  - il17rc
  - traf3ip2b
  - traf6
  - traf3
  - mak
  - il17c
  - cebpb
  - il17rd
  - kita
  - ngfra
  - il17d
  - IL17A
  - IL17RA
  - IL17F
  - IL17RC
  - TRAF3IP2
  - TRAF6
  - TRAF1
  - TRAF2
  - TRAF3
  - TRAF4
  - TRAF5
  - TRAF7
  - IL25
  - SGSM3
  - MAK
  - ALPK3
  - EPHB2
  - MAPK1
  - MAPK3
  - IL17RB
  - IL17C
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - IL17RE
  - CEBPB
  - NFKB1
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - ETS1
  - ETS2
  - IL17B
  - IL17RD
  - IL17D
---
